Themis Bioscience News Today

Annual general meeting of Medigene AG on 24 June 2024 Convenience Translation Gerd Zettlmeissl, PhD ...

Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.

European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), announced today the success of a €20M Series B fundraising led by Relyens

Major players in the cancer vaccines market are GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi Pasteur,...

Climate change and other environmental factors could cause Lassa fever to spread to additional regions within Africa, new research predicts. CEPI is the leading funder of research into vaccines against the potentially deadly virus.

/PRNewswire/ -- The "Cancer Vaccines Global Market Report 2022: By Type, By Technology, By Cancer, By End-User" report has been added to...

Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Global Market Report 2022: By Type, By Technology, By Cancer, By End-User" report has...

The "Cancer Vaccines Global Market Report 2022: By Type, By Technology, By Cancer, By End-User" report has been added to ResearchAndMarkets.com's offe

DUBLIN--(BUSINESS WIRE)--The "Cancer Vaccines Global Market Report 2022: By Type, By Technology, By Cancer, By End-User" report has been added to ResearchAndMarkets.com's offering.The global cancer vaccines market is expected to grow from $4.47 billion in 2021 to $5.29 billion in 2022 at a compound annual growth rat...

The death of a new-born baby with Lassa fever in the UK last week has raised concerns about the global threat posed by deadly infectious diseases.